Compare
NAVs as of 20 Aug 2026
Add a second fund to compare. Until then every figure below is shown against the Sectoral/ Thematic median (248 funds), which is the only comparison one fund can support.
Growth of ₹100 (rebased over the selected window)
Common period 17 Jan 2008 – 20 Aug 2026. Every series is rebased to ₹100 at the start of this window. Benchmark lines are the category index WealthTicker measures against, which is not always the benchmark the scheme itself declares — the fund page’s Scheme Info names that one. Nifty 500 history starts 25 Jul 2016, so that benchmark is not plotted over this window — pick a shorter range to see it.
View as table
| Date | Franklin Asian Equity Fund |
|---|---|
| 17 Jan 2008 | ₹100.00 |
| 05 Aug 2009 | ₹102.88 |
| 22 Feb 2011 | ₹113.26 |
| 10 Sep 2012 | ₹126.29 |
| 29 Mar 2014 | ₹136.29 |
| 16 Oct 2015 | ₹135.74 |
| 04 May 2017 | ₹136.42 |
| 21 Nov 2018 | ₹130.75 |
| 09 Jun 2020 | ₹140.04 |
| 27 Dec 2021 | ₹153.67 |
| 15 Jul 2023 | ₹135.73 |
| 31 Jan 2025 | ₹140.81 |
| 20 Aug 2026 | ₹226.98 |
| Metric | Franklin Templeton · Regular · IDCW NAV ₹21.55 Very High risk ★★★☆☆ | Category median Sectoral/ Thematic · 248 funds |
|---|---|---|
| +43.65% | +3.54% | |
| +21.91% | +11.47% | |
| +7.15% | +9.70% | |
| +4.89% | +10.32% | |
| +4.51% | +9.15% | |
| +18.63% | — | |
| +3.35% | +12.10% | |
| +2.65% | +10.32% | |
| +2.31% | +8.80% | |
| Risk | ||
| 16.85% | 15.91% | |
| 0.91 | 0.25 | |
| 1.30 | 0.32 | |
| -43.91% | -26.14% | |
| Nifty 500 | — | |
| +11.41% | -0.04% | |
| 0.56 | 0.98 | |
| 72.7% | 98.3% | |
| -5.6% | 101.5% | |
| 2.57% | 2.38% | |
| ₹720.84Cr | ₹1,160Cr | |
| 1.00% | — | |
| None | — | |
| ₹500 | — | |
| ₹5.00K | — | |
| 7% | 42% | |
| Sandeep Manam · 4.8y | — | |
| 17 Jan 2008 | — | |
| 29 | — | |
| 20.1% | — | |
| 8.8% | — | |
Best marks the strongest value in a row, and only where the gap is bigger than noise — a near-tie is left unmarked rather than dressed up as a result. SIP XIRR is a ₹10,000/month instalment over 5 years of real NAV history. Nothing here is supplied by a fund house. For research only — not investment advice.